Article Abstract

Role of acute kidney injury biomarkers to guide renal replacement therapy initiation, what we learn from EARLY-RRT trial and FST trial?

Authors: Nattachai Srisawat, Kamonwan Tangvoraphonkchai, Nuttha Lumlertgul, Kriang Tungsanga, Somchai Eiam-Ong


We wrote this letter to the editor in response to the commentary by Hoste et al., and Meersch et al., on our trial “The effect of early Renal Replacement Therapy guided by plasma Neutrophil Gelatinase Associated Lipocalin on outcome of Acute Kidney Injury: a feasibility study (EARLY-RRT)” trial which was recently published in the Journal of Critical Care (1).

Article Options

Download Citation